Company Filing History:
Years Active: 2022
Title: Innovator Spotlight: Allí Klosner
Introduction
Allí Klosner is an accomplished inventor based in Fullerton, California. He has made significant contributions to the field of nutritional supplements through his innovative work on bilayer tablets of B vitamins. His unique approach to vitamin delivery has the potential to enhance the effectiveness of oral administration.
Latest Patents
Klosner holds a patent for "Bilayer tablets of B vitamins and process for preparing the same." This patent describes compositions for oral administration, particularly in the form of bilayer tablets that include B vitamins for modified delivery. The bilayer multi-B vitamin tablets offer immediate release of a first set of B vitamins, such as riboflavin (B2) and cyanocobalamin (B12), followed by controlled release of a second set of B vitamins, including folic acid, biotin, niacinamide (B3), pyridoxine (B6), pantothenic acid (B5), and thiamine (B1). This innovative formulation aims to improve the bioavailability and effectiveness of B vitamins in the body.
Career Highlights
Allí Klosner is currently associated with Access Business Group International LLC, where he continues to develop and refine his innovative products. His work has garnered attention for its potential impact on health and wellness, particularly in the realm of dietary supplements.
Collaborations
Klosner has collaborated with notable colleagues, including David S. Chang and Dawna Salter Venzon. These partnerships have contributed to the advancement of his research and the successful development of his patented products.
Conclusion
Allí Klosner's innovative approach to B vitamin delivery through bilayer tablets represents a significant advancement in nutritional science. His contributions have the potential to improve health outcomes for many individuals seeking effective vitamin supplementation.